Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples